Cargando…
Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Increasing environmental distress is associated with a growing asthma incidence; no treatments are available but montelukast (MTK)—an antagonist of the cysteinyl leukotrienes receptor 1—is widely used in the management of symptoms among adults and children. Recently, new molecular targets have been...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505853/ https://www.ncbi.nlm.nih.gov/pubmed/36145259 http://dx.doi.org/10.3390/ph15091039 |